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INTRODUCTION
 Urinary tract infection (UTI) is among the most 
frequent bacterial infections in clinical practice 
worldwide. The frequency and burden of UTI 
is mostly underestimated and speculated to be 
higher than available data because it is not among 
 Correspondence: 
 Dr. Md. Abdus Salam
 E-mail: abdussalam@iium.edu.my
  * Received for Publication: May 21, 2020
  * 1st Revision Received: June 15, 2020
  * 2nd Revision Received: July 20, 2020
  * Final Revision Accepted: July 25, 2020
Original Article
High prevalence of multidrug resistant uropathogens: 
A recent audit of antimicrobial susceptibility testing 
from a tertiary care hospital in Bangladesh
Chandrika Dasgupta1, Md. Abdur Rafi2, Md. Abdus Salam3
ABSTRACT
Objectives: Urinary tract infections due to multi drug resistant bacteria have been on the rise globally 
with serious implications for public health. The objective of this study was to explore the prevalence of 
multi drug resistant uropathogens and to correlate the urinary tract infections with some demographic and 
clinical characteristics of patients admitted in a tertiary care hospital in Bangladesh. 
Methods: A cross sectional prospective study was conducted at Shaheed Ziaur Rahman Medical College 
Hospital, Bogura, Bangladesh among clinically suspected urinary tract infection patients from January to 
December, 2018. Clean-catch midstream or catheter-catch urine samples were subjected to bacteriological 
culture using chromogenic agar media. Antimicrobial susceptibility testing of the isolates was done by Kirby-
Bauer disk diffusion method following Clinical and Laboratory Standards Institute guidelines. Descriptive 
statistical methods were used for data analysis. 
Results: Culture yielded a total of 537 (42.8%) significant bacterial growths including 420 (78.2%) multi 
drug resistant uropathogens from 1255 urine samples. Escherichia coli was the most common isolate 
(61.6%) followed by Klebsiella spp. (22.5%), Pseudomonas spp. (7.8%), Staphylococcus aureus (5.4%) and 
Enterobacter spp. (2.6%) with multi drug resistance frequency of 77.6%, 71.9%, 90.5%, 86.2% and 92.9% 
respectively. There was female preponderance (M:F; 1:1.97; P=0.007) but insignificant differences between 
paediatric and adult population (43.65% vs. 42.57%) and also among different age groups. Diabetes, chronic 
renal failure, fever and supra-pubic pain had significant association as co-morbidities and presentations 
of urinary tract infections (P<0.05). Multi drug resistance ranged from 3.7 to 88.1% including moderate to 
high resistance found against commonly used antibiotics like ciprofloxacin, cephalosporin, azithromycin, 
aztreonam, cotrimoxazole and nalidixic acid (28.6 to 92.9%). Isolates showed 2.4 to 32.2% resistance 
to nitrofurantoin, amikacin, netilmicin and carbapenems except Pseudomonas spp. (66.7% resistance to 
nitrofurantoin) and Enterobacter spp. (28.6 to 42.9% resistance to carbapenems).
Conclusion: There is very high prevalence of multi drug resistant uropathogens among hospitalized patients 
and emergence of carbapenem resistance is an alarming situation. Antibiotic stewardship program is highly 
recommended for hospitals to combat antimicrobial resistance. 
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mandatory notifiable diseases.1 A spectrum of 
clinical scenario from asymptomatic bacteriuria 
to complicated infections are observed in UTI 
affecting different age groups. Dysuria with or 
without frequency, urgency, and suprapubic 
pain are the usual accompaniments of lower 
urinary tract infections while complicated 
UTI like pyelonephritis usually presents with 
systemic symptoms like fever, chill, flank pain, 
hematuria and delirium.2 Escherichia coli remains 
the predominant uropathogen (80%) followed by 
Klebsiella, Enterobacter, Proteus, Pseudomonas and 
Enterococci. The pathogens traditionally associated 
with UTI are on a change particularly because of 
growing antimicrobial resistance and underlying 
host factors.3
 UTI is becoming increasingly difficult to treat 
owing to high recurrence and multi drug resistant 
(MDR) uropathogens especially extended-
spectrum β-lactamases (ESBLs) producing bacteria 
that have been on the rise globally with serious 
implications for public health.4 Traditionally 
broad spectrum antibiotics remain the drug of 
choice to treat UTI but indiscriminate use of 
antibiotics is making the treatment challenging 
as it accelerates the emergence of drug resistant 
bacteria. This practice is more common in lower 
and middle income countries like Bangladesh, 
where empirical therapy is a common practice 
as the laboratory facility for urine culture is not 
widely available.5 Although bacterial etiology 
of UTI and antimicrobial resistance pattern may 
have regional variations and largely depend on 
the antibiotic policy of health care facility but 
the growing frequency of MDR uropathogens 
has become now a universal problem and more 
alarming in the developing countries including 
Bangladesh.6,7
 Routine antimicrobial susceptibility testing is a 
pre-requisite not only to choose the appropriate 
antibiotic but also to facilitate the empiric therapy.8 
The present investigation was carried out to explore 
the current prevalence of MDR uropathogens, 
frequency of resistance to different classes of 
antibiotics and to correlate UTI with patient’s 
demographic and clinical characteristics from a 
tertiary care hospital in Bangladesh.
METHODS
 This cross sectional prospective investigation 
was conducted from January to December, 2018 
among one thousand two hundred fifty-five (1255) 
admitted patients of different age and gender of 
Shaheed Ziaur Rahman Medical College Hospital 
(SZMCH), Bogura, a 1000-bed tertiary care teaching 
hospital in the Northern part of Bangladesh. 
Patients with at least one of the clinical features 
of UTI (fever, dysuria, frequency, urgency, supra-
pubic pain, loin pain, haematuria, nocturia or prior 
history of UTI) were judged as clinically suspected 
and selected for confirmation by laboratory tests. 
Clean-catch midstream or catheter-catch urine was 
collected into a sterile wide mouth container/test 
tube with all aseptic measures and was screened 
for microscopic demonstration of pus cells ≥ 5/ 
HPF (high power field) in a centrifuged deposit 
before considering culture.9
 Ethical Review Committee of Shaheed Ziaur 
Rahman Medical College, Bogura, Bangladesh 
approved the protocol and informed written 
consent/assent was taken from patient (Ref: 
SMZC/2016/351, Dated: 10-12-2016). 
Urine culture: Chromogenic agar (HiMedia, India) 
medium was used for urine culture and samples 
were inoculated aseptically using a calibrated wire 
loop of 28G (internal diameter 3.26 mm) holding 
0.004 ml of urine for overnight aerobic incubation 
at 370C. Details of culture technique, significant 
bacteriuria and identification methods have been 
reported previously.10 The final identification of 
the isolates was done using standard identification 
protocol such as Gram’s staining, motility test, 
catalase test, coagulase test, oxidase test and 
relevant biochemical tests as appropriate for 
the isolates.11 Diagnosis of UTI was established 
on the basis of presenting feature(s), pyuria and 
significant bacteriuria.
Antimicrobial susceptibility testing (AST): 
Mueller-Hinton agar and Kirby-Bauer disk 
diffusion method12 were used for AST against a 
panel of 17 commercial antibiotic disks (Oxoid, 
UK): amikacin (30µg), azithromycin (15µg), 
aztreonam (30μg), cefuroxime sodium (30µg), 
cefixime (5µg), cefepime (30µg), ceftazidime 
(30µg), ceftriaxone (30µg), ciprofloxacin (10μg), 
cotrimoxazole (25µg), gentamicin (30μg), 
imipenem (10µg), levofloxacin (5μg), meropenem 
(10µg), nalidixic acid (30µg), netilmicin (30μg) 
and nitrofurantoin (300µg). Isolates were labeled 
as ‘sensitive’ and ‘resistant’ according to the 
guidelines of Clinical Laboratory Standard 
Institute (CLSI). Escherichia coli ATCC 25922 and 
Staphylococcus aureus ATCC 25923 were used as 
control strains for AST.13 Resistance to at least one 
agent in three or more antimicrobial categories 
was defined as multi drug resistance.14
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Data collection and statistical analysis: A 
structured questionnaire was used for patient’s 
demographic and clinical data. Descriptive 
statistical methods in SPSS (version 21.0 for 
Windows, SPSS® Inc., Chicago, IL) were applied 
for data analysis. The antimicrobial resistance 
prevalence was calculated as the proportion of 
positive results against total sample. Nominal 
variables were shown as number of cases (n) 
and percentage (%). Test of significance was 
performed using the Chi-square (χ2) test and 
variables including demographic and clinical 
characteristics of UTI patients were compared 
using cross-tabulation statistical methods. P < 0.05 
was considered statistically significant.
RESULTS
 Culture yielded 537 (42.8%) as positive out of 
1255 clinically suspected UTI patients. Escherichia 
coli was the most common (61.6%) gram negative 
isolate followed by Klebsiella spp. (22.5%), 
Pseudomonas spp. (7.8%) and Enterobacter spp. (2.6%), 
while Staphylococcus aureus (5.4%) was the only 
gram positive isolate. Of 537 isolates, 420 (78.2%) 
were found to be MDR with frequency distribution 
of Escherichia coli, Klebsiella spp., Pseudomonas spp., 
Staphylococcus aureus and Enterobacter spp. was 
77.6%, 71.9%, 90.5%, 86.2% and 92.9% respectively 
(Table-I).
 There was female preponderance (M:F; 1:1.97) 
among culture-positive cases and statistically 
highly significant (P=0.007). Age distribution 
revealed 252 (20%) patients from paediatric age 
Prevalence of MDR-uropathogens
Table-I: Frequency of culture-positive (n = 537)
and MDR (n = 420) uropathogens.
 Uropathogens Frequency of  Frequency of 
 culture-positive MDR
 isolates n (%) isolates n (%)
Escherichia coli 331 (61.6) 257 (77.6)
Klebsiella spp. 121 (22.5) 87 (71.9)
Pseudomonas spp. 42 (7.8) 38 (90.5)
Staphylococcus aureus 29 (5.4) 25 (86.2)
Enterobacter spp. 14 (2.6) 13 (92.9)
Total 537 (100) 420 (78.2)
Table-II: Correlation of UTI with demographic and clinical characteristics of the patients.
Characteristics Culture-positive n(%) Culture-negative n(%) Total n(%) P-value
Gender    
   Female 356 (66.3) 422 (58.8) 778 (62.0) 0.007
   Male 181 (33.7) 296 (41.2) 477 (38.0) 
Age
   < 5 years 70 (13.0) 92 (12.8) 162 (12.9) 0.994
   5 – 18 years 40 (7.4) 50 (7.0) 90 (7.2) 
   19 – 30 years 95 (17.7) 135 (18.8) 230 (18.3) 
   31 – 40 years 65 (12.1) 92 (12.8) 157 (12.5) 
   41 – 50 years 71 (13.2) 98 (13.6) 169 (13.5) 
   51 – 60 years 83 (15.5) 104 (14.5) 187 (14.9) 
   > 60 years 113 (21.0) 147 (20.5) 260 (20.7) 
Chronic Medical Conditions
   Hypertension 108 (20.1) 140 (19.5) 248 (19.8) 0.487
   Diabetes mellitus 139 (25.8) 92 (12.8) 231 (18.4) 0.004
   Ischaemic heart disease 20 (3.7) 32 (4.4) 52 (4.1) 0.364
   Chronic obstructive pulmonary disease 21 (3.9) 28 (3.8) 49 (3.9) 0.148
   Chronic renal failure 23 (4.2) 16 (2.2) 39 (3.1) 0.029
   Asthma 11 (2.1) 17 (2.3) 28 (2.2) 0.774
Clinical presentation
   Dysuria  432 (80.5) 559 (77.8) 991 (79.0) 0.372
   Frequency 296 (55.1) 375 (52.2) 671 (53.5) 0.143
   Fever 257 (47.8) 166 (23.2) 423 (33.7) 0.012
   Urgency 192 (35.7) 206 (28.7) 398 (31.7) 0.271
   Supra-pubic pain 158 (29.4) 174 (24.2) 332 (26.5) 0.048
   Nocturia 84 (15.6) 98 (13.6) 182 (14.5) 0.153
   Haematuria 30 (5.6) 32 (4.4) 62 (4.9) 0.076
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group (up to 18 yrs.) and 1003 (80%) adults with 
no significant difference in frequency of culture-
positive cases (43.7% vs. 42.6%). Also there was no 
statistical significance in rate of isolation among 
different age groups. Co-morbid conditions like 
hypertension (19.8%), diabetes mellitus (18.4%), 
ischaemic heart disease (4.1%), chronic obstructive 
pulmonary disease (3.9%), chronic renal failure 
(3.1%) and asthma (2.2%) were noted among UTI 
patients with significant (P < 0.05) association 
observed for diabetic and chronic renal failure 
patients. Among symptoms, dysuria (79%), 
frequency (53.5%), fever (33.7%), urgency (31.7%), 
supra-pubic pain (26.5%), nocturia (14.5%) 
and haematuria (4.9%) were noted with fever 
and supra-pubic pain had significant (P < 0.05) 
association with UTI (Table-II). 
 MDR ranged from 3.7 to 88.1% and isolates 
were found to be moderate to highly resistant 
(28.6 to 92.9%) to commonly used antibiotics 
like ciprofloxacin, cotrimoxazole, azithromycin, 
nalidixic acid, cephalosporin and aztreonam 
(Table-III). Nitrofurantoin, amikacin, netilmicin, 
imipenem and meropenem were found to be better 
choice (resistance ranged from 2.4 to 32.2%) for all 
isolates, except Pseudomonas spp. and Enterobacter 
spp. Nitrofurantoin resistance was 66.7% for 
Pseudomonas spp. while Enterobacter spp. showed 
moderate resistance to both imipenem (28.6%) and 
meropenem (42.9%).
DISCUSSION
 Resistance to commonly used antibiotics is an 
emerging concern worldwide causing treatment 
failure in different infections including UTI.15 The 
present study highlights a baseline evidence on 
current situation of very high frequency of MDR 
uropathogens among hospitalized patients. It is 
no wonder that we found female preponderance 
which is an established fact that due to many 
inherent host factors females are more vulnerable 
to UTI.4 Diabetes and chronic renal failure were 
found to have statistically significant association 
with UTI and these findings corroborate well with 
other reports.16,17 Predisposition to UTI in diabetes 
results from several factors including increased 
susceptibility to uncontrolled glycaemia and 
defective host immunity. While chronic renal failure 
is a risk factor for UTI due to metabolic disorders 
resulting in secondary immunodeficiency.
 Fever and supra pubic pain had significant 
association among others as presentations of 
UTI. Fever usually denotes pyelonephritis and 
more commonly observed in paediatric patients 
while supra pubic pain indicates cystitis which 
is common among lower UTI.18 Escherichia 
coli was the most frequent isolate followed by 
Klebsiella spp., which is consistent with many 
previous studies.4,6,8,10 In fact, E. coli stands alone 
for around 70% as the etiological agent of both 
community and hospital acquired UTI.4 We found 
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Table-III: Frequency of antimicrobial resistance of uropathogens (n = 537).
Antimicrobial Escherichia coli Klebsiella spp. Pseudomonas spp. Staphylococcus Enterobacter Total
   Agents (n = 331)  (n = 121)  (n = 42) aureus (n = 29) spp. (n = 14) MDR n (%)
Cefixime 187 (56.5) 74 (61.2) 25 (59.5) 12 (41.4) 11 (78.6) 309 (57.5)
Ceftriaxone 166 (50.2) 69 (57.0) 16 (38.1) 3 (10.3) 7 (50.0) 261 (48.6)
Ceftazidime 128 (38.7) 53 (43.8) 12 (28.6) 9 (31.0) 10 (71.4) 212 (39.5)
Cefepime 158 (47.7) 57 (47.1) 13 (31.0) 10 (34.5) 10 (71.4) 248 (46.2)
Amikacin 29 (8.8) 16 (13.2) 2 (4.8) 2 (6.9) 3 (21.4) 52 (9.7)
Gentamicin 134 (40.5) 55 (45.5) 22 (52.4) 13 (44.8) 9 (64.3) 233 (43.4)
Imipenem 9 (2.7) 5 (4.1) 1 (2.4) 1 (3.4) 4 (28.6) 20 (3.7)
Meropenem 8 (2.4) 9 (7.4) 2 (4.8) 2 (6.9) 6 (42.9) 27 (5.0)
Ciprofloxacin 189 (57.1) 46 (38.0) 14 (33.3) 18 (62.1) 10 (71.4) 277 (51.6)
Levofloxacin 173 (52.3) 41 (33.9) 12 (28.6) 4 (13.8) 10 (71.4) 240 (44.7)
Azithromycin 178 (53.8) 66 (54.5) 20 (47.6) 18 (62.1) 9 (64.3) 291 (54.2)
Cefuroxime 154 (46.5) 70 (57.9) 26 (61.9) 18 (62.1) 9 (64.3) 277 (51.6)
Aztreonam 131 (39.6) 61 (50.4) 12 (28.6) 24 (82.8) 13 (92.9) 241 (44.9)
Cotrimoxazole 192 (58.0) 66 (54.5) 35 (83.3) 20 (69.0) 8 (57.1) 321 (59.8)
Nitrofurantoin 68 (20.5) 39 (32.2) 28 (66.7) 5 (17.2) 3 (21.4) 143 (26.6)
Netilmicin 60 (18.1) 38 (31.4) 10 (23.8) 8 (27.6) 3 (21.4) 119 (22.2)
Nalidixic Acid 292 (88.2) 110 (90.9) 35 (83.3) 24 (82.8) 12 (85.7) 473 (88.1)
N.B. Figures in the parentheses indicate percentage.
Staph aureus as only gram positive uropathogen 
and it coincides with other report.19 Although 
coagulase negative Staph saprophyticus has been 
reported as frequent uropathogen usually from 
patients attending outpatient or antenatal clinics 
but it contradicts with ours because we included 
hospital admitted cases where Staph aureus is a 
common pathogen.4,5,17
 High prevalence of MDR uropathogens with 
moderate to high resistance to most of the common 
antimicrobial classes including cephalosporin, 
quinolone and fluoroquinolones, macrolide, 
cotrimoxazole and injectable drugs like aztreonam 
and gentamicin was observed in the present study 
which is higher in comparison to our previous 
report.5 This difference can be correlated with 
inclusion of hospital acquired UTI in the present 
setting where there is high frequency of MDR 
uropathogens.20 Comparable prevalence rate of 
MDR uropathogens to commonly prescribed 
antimicrobials has also been reported by some 
recent studies.21,22
 We found nitrofurantoin and amikacin as 
better choice except Pseudomonas spp. which is 
consistent with our previous report and other 
recent studies.5,23,24 Reasons for the emergence 
of low resistance to nitrofurantoin are not fully 
understood, but likely include its restricting use, 
limited systemic absorption and the need for 
multiple genetic mutations in bacteria to develop 
resistance. The most important and alarming 
findings of the present study are variable degree 
of resistance to carbapenems ranging from 2.4 
to 42.9% shown by different isolates which 
corroborates with others.23,25 Carbapenems 
are the latest developed β-lactam containing 
broad spectrum antibiotics usually reserved for 
MDR pathogens. Lately, the dissemination of 
community acquired E. coli capable of producing 
ESBLs that can hydrolyze almost all β-lactams 
except carbapenems has been reported worldwide; 
consequently, the use and abuse of carbapenems 
have increased greatly with emergence of 
carbapenem resistance as a serious concern. 
Evidence based choice of antibiotics from in-vitro 
antimicrobial susceptibility test may reduce the 
risk of this alarming situation when there is current 
shortage of effective therapies, lack of successful 
preventive measures and of course very slow 
development of novel treatment options. Further, 
practice of Antibiotic Stewardship Programs 
(ASPs) in hospitals can help minimizing the 
problem of antibiotic resistance and it has been 
recommended by the Centers for Disease Control 
and Prevention (CDC). ASPs refer to optimizing 
the use of antibiotics to effectively treat 
infections, protect patients from harms caused by 
unnecessary antibiotic use and combat antibiotic 
resistance. The programs have at least seven core 
components to help clinicians to improve clinical 
outcomes by improving antibiotic prescribing 
practice (https://www.cdc.gov/antibiotic-use/
healthcare/pdfs/hospital-core-elements-H.pdf).
Limitations of the study: First of all, it was a 
single center study, so the findings cannot be 
generalized in the national context. Second, the 
detailed clinical classification of UTI patients 
could not be mentioned. Third, the genotypic or 
phenotypic categorization of MDR uropathogens 
were not established.
CONCLUSIONS
 Increasing frequency of MDR uropathogens 
is a global concern and has been reinforced by 
our findings. Commonly prescribed antibiotics 
including third generation cephalosporin and 
fluoroquinolones have shown to be poorly 
efficacious while nitrofurantoin, netilmicin and 
amikacin still hold some promise. Although 
the reserve drugs like carbapenems are still the 
best choice in treating the hospital acquired UTI 
but emergence of carbapenem resistance is a 
great concern. Antibiotic Stewardship Programs 
(ASPs) can only optimize the use of antibiotics 
to effectively treat infections and to improve 
clinical outcomes. We strongly advocate the 
introduction of ASPs in the tertiary care hospitals 
in Bangladesh to combat antibiotic resistance.
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